Relationship Between Vitamin B12 and Sensory and Motor Peripheral Nerve Function in Older Adults

Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Journal of the American Geriatrics Society (Impact Factor: 4.57). 06/2012; 60(6):1057-63. DOI: 10.1111/j.1532-5415.2012.03998.x
Source: PubMed


To examine whether deficient B12 status or low serum B12 levels are associated with worse sensory and motor peripheral nerve function in older adults.
Health, Aging and Body Composition Study.
Two thousand two hundred and eighty-seven adults aged 72 to 83 (mean 76.5 ± 2.9; 51.4% female; 38.3% black).
Low serum B12 was defined as serum B12 less than 260 pmol/L, and deficient B12 status was defined as B12 less than 260 pmol/L, methylmalonic acid (MMA) greater than 271 nmol/L, and MMA greater than 2-methylcitrate. Peripheral nerve function was assessed according to peroneal nerve conduction amplitude and velocity (NCV) (motor), 1.4 g/10 g monofilament detection, average vibration threshold detection, and peripheral neuropathy symptoms (numbness, aching or burning pain, or both) (sensory).
B12-deficient status was found in 7.0% of participants, and an additional 10.1% had low serum B12 levels. B12 deficient status was associated with greater insensitivity to light (1.4 g) touch (odds ratio = 1.50, 95% confidence interval = 1.06-2.13) and worse NCV (42.3 vs 43.5 m/s) (β = -1.16, P = .01) after multivariable adjustment for demographics, lifestyle factors, and health conditions. Associations were consistent for the alternative definition using low serum B12 only. No significant associations were found for deficient B12 status or the alternative low serum B12 definition and vibration detection, nerve conduction amplitude, or peripheral neuropathy symptoms.
Poor B12 (deficient B12 status and low serum B12) is associated with worse sensory and motor peripheral nerve function. Nerve function impairments may lead to physical function declines and disability in older adults, suggesting that prevention and treatment of low B12 levels may be important to evaluate.

Download full-text


Available from: Eef Hogervorst, May 13, 2014

Click to see the full-text of:

Article: Relationship Between Vitamin B12 and Sensory and Motor Peripheral Nerve Function in Older Adults

302.54 KB

See full-text
  • Source
    • "Neurologic damage, a possible consequence of metformin-induced vitamin B12 deficiency, can present as peripheral neuropathy and may be mistaken for diabetic neuropathy in patients on metformin treatment (10). Low vitamin B12 levels have been reported to be associated with worse nerve conduction velocities and poorer responses to light touch by monofilament detection (27). This may lead to the unnecessary use of anticonvulsants or tricyclic antidepressants (10, 28, 29). "
    [Show abstract] [Hide abstract]
    ABSTRACT: We evaluated the prevalence of vitamin B12 deficiency and associated factors in type 2 diabetes patients using metformin. A total of 799 type 2 diabetes patients using metformin was enrolled. Vitamin B12 and folate levels were quantified by chemiluminescent enzyme immunoassay. Vitamin B12 deficiency was defined as vitamin B12 ≤ 300 pg/mL without folate deficiency (folate > 4 ng/mL). The prevalence of vitamin B12 deficiency in metformin-treated type 2 diabetes patients was 9.5% (n = 76), and the mean vitamin B12 level was 662.5 ± 246.7 pg/mL. Vitamin B12 deficient patients had longer duration of metformin use (P < 0.001) and higher daily metformin dose (P < 0.001) than non-deficient patients. Compared with daily metformin dose of ≤ 1,000 mg, the adjusted odds ratio for 1,000-2,000 mg, and ≥ 2,000 mg were 2.52 (95% CI, 1.27-4.99, P = 0.008) and 3.80 (95% CI, 1.82-7.92, P < 0.001). Compared with metformin use of < 4 yr, the adjusted odds ratios for 4-10 yr, and ≥ 10 yr were 4.65 (95% CI, 2.36-9.16, P < 0.001) and 9.21 (95% CI, 3.38-25.11, P < 0.001), respectively. In conclusion, our study indicates that patients with type 2 diabetes treated with metformin should be screened for vitamin B12 deficiency, especially at higher dosages (> 1,000 mg) and longer durations (≥ 4 yr) of treatment. Graphical Abstract
    Journal of Korean Medical Science 07/2014; 29(7):965-72. DOI:10.3346/jkms.2014.29.7.965 · 1.27 Impact Factor
  • Source
    • "This finding is consistent with classic clinical descriptions of SCD, in which damage to the corticospinal tract (lateral columns) is characterized by a pyramidal syndrome and weakness in the lower extremities in the later stages of the disease (Di Lazzaro et al. 1992; Hemmer et al. 1998). A recent study in older adults reported that B12 deficiency was associated with hypoesthesia to light touch and impairment of sensory and motor peripheral nerve conduction velocity (Leishear et al. 2012). These findings are consistent with those described by Tredici et al. (1998), who reported damage to both thick and thin myelin peripheral fibers. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Introduction: Vitamin B12 deficiency causes neurologic and psychiatric disease, especially in older adults. Subacute combined degeneration is characterized by damage to the posterior and lateral spinal cord affecting the corticospinal tract. Objective: To test corticospinal tract projections using motor evoked potentials (MEPs) by transcranial magnetic stimulation (TMS) in asymptomatic older adults with low vitamin B12 (B12) levels. Methods: Cross-sectional study of 53 healthy older adults (>70 years). MEPs were recorded in the abductor pollicis brevis and tibialis anterior muscles, at rest and during slight tonic contraction. Central motor conduction time (CMCT) was derived from the latency of MEPs and peripheral motor conduction time (PMCT). Neurophysiological variables were analyzed statistically according to B12 status. Results: Median age was 74.3 ± 3.6 years (58.5% women). Twenty-six out of the 53 subjects had low vitamin B12 levels (B12 < 221 pmol/l). MEPs were recorded for all subjects in upper and lower extremities. There were no significant differences in either latency or amplitude of MEPs and CMCT between low and normal B12 groups. There was a significant PMCT delay in the lower extremities in the low B12 group (p = 0.014). Conclusions: No subclinical abnormality of the corticospinal tract is detected in asymptomatic B12-deficient older adults. The peripheral nervous system appears to be more vulnerable to damage attributable to this vitamin deficit. The neurophysiological evaluation of asymptomatic older adults with lower B12 levels should be focused mainly in peripheral nervous system evaluation.
    Somatosensory & Motor Research 04/2014; 31(3). DOI:10.3109/08990220.2014.897603 · 0.64 Impact Factor
  • Source
    • "The effective use of vitamin B supplements has been described for prevention of cardiovascular disease in patients with kidney disease.10 Likewise, it has been reported that patients taking vitamin B supplements, in particular folate, have significant improvement in their signs and symptoms of diabetic peripheral neuropathy.11–17 A commercially available vitamin B compound reported to reduce anesthesia, paresthesia, causalgia, and other symptoms of homocysteine associated with vascular damage is Metanx® (Pamlab, Covington, LA, USA). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to determine whether a combination of vitamins B6, B9, and B12 is an effective intervention for reducing the signs and symptoms of nonproliferative diabetic retinopathy. Ten subjects with type 2 diabetes mellitus (n = 20 eyes) with clinically diagnosed mild to moderate nonproliferative diabetic retinopathy were recruited from a private practice ophthalmology clinic for this open-label, uncontrolled, prospective six-month study. Metanx® vitamin tablets (containing 3 mg L-methylfolate calcium, 35 mg pyridoxal-5'-phosphate, and 2 mg methylcobalamin) were administered at a dosage of two tablets daily. Primary outcome indicators were the percent change in mean retinal sensitivity threshold measured by macular microperimetry and the percent change in mean central retinal thickness measured by spectral-domain optical coherence tomography. Three subjects were lost to follow-up. In the remaining seven subjects, two of 14 eyes had foveal edema that prevented microperimetry measurements due to poor fixation. The remaining 12 eyes showed a nonlinear improvement in mean threshold retinal sensitivity (P < 0.001). Overall change in mean central retinal thickness in 14 eyes was linear (R(2) = 0.625; P = 0.034), with a significant reduction between one and six months (P = 0.012). In this pilot study, the Metanx intervention appeared to have some beneficial effects with respect to reducing retinal edema and increasing light sensitivity in subjects with nonproliferative diabetic retinopathy.
    Clinical ophthalmology (Auckland, N.Z.) 07/2013; 7:1451-8. DOI:10.2147/OPTH.S46718
Show more